Home › Funds › BRADLEY FOSTER & SARGENT INC/CT › IDXX

BRADLEY FOSTER & SARGENT INC/CT position in IDXX

IDEXX LABS INC · Health Care

BRADLEY FOSTER & SARGENT INC/CT reported holding 104,564 shares of IDXX (IDEXX LABS INC) in its Q3 2026 13F filing — a position valued at US$54.6M, representing 0.78% of its reported portfolio and ranking #34 among its reported holdings. BRADLEY FOSTER & SARGENT INC/CT has disclosed IDXX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)104.56K sh
Reported value held$54.60M
Portfolio Weight0.78%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How BRADLEY FOSTER & SARGENT INC/CT's IDXX position evolved

BRADLEY FOSTER & SARGENT INC/CT first disclosed a stake in IDXX in Q3 2023 at 1,140 shares (US$573K). The position peaked in Q4 2025 at 104,693 shares, worth US$70.8M. Across 13 filings, BRADLEY FOSTER & SARGENT INC/CT increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 104,564 shares valued at US$54.6M. Notable position changes include a 321% increase in Q3 2024 (shares fell 18% over the following quarter), a 2001% increase in Q4 2024 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.14K $572.54K New
Q4 2023 1.14K $632.76K Hold
Q1 2024 1.01K $548.03K Reduce
Q2 2024 1.00K $488.66K Reduce
Q3 2024 4.22K $2.13M Add
Q4 2024 88.71K $36.68M Add
Q1 2025 103.85K $43.61M Add
Q2 2025 104.69K $56.15M Add
Q3 2025 105.11K $67.15M Hold
Q4 2025 104.69K $70.83M Hold
Q1 2026 103.65K $58.24M Reduce
Q2 2026 104.14K $54.82M Hold
Q3 2026 104.56K $54.60M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IDXX and 13F data

IDXX (IDEXX LABS INC) is a Health Care company. 26 other funds we track also report a position in IDXX — the largest reported positions include Baron Funds (US$1.04B), BAMCO INC /NY/ (US$930.8M), BLAIR WILLIAM & CO/IL (US$442.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IDXX

All IDXX fund holders →

FAQ

How long has BRADLEY FOSTER & SARGENT INC/CT held IDXX?

BRADLEY FOSTER & SARGENT INC/CT has disclosed IDXX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BRADLEY FOSTER & SARGENT INC/CT's current position in IDXX?

As of Q3 2026, BRADLEY FOSTER & SARGENT INC/CT holds 104.56K shares of IDXX (IDEXX LABS INC), valued at $54.60M, representing 0.78% of its reported portfolio and ranking #34.

Has BRADLEY FOSTER & SARGENT INC/CT been buying or selling IDXX?

In the latest 13F filing (Q3 2026), BRADLEY FOSTER & SARGENT INC/CT held unchanged its position in IDXX. The position peaked in Q4 2025 at 104.69K shares.

Which other funds hold IDXX?

Other major institutional holders of IDXX include Baron Funds, BAMCO INC /NY/, BLAIR WILLIAM & CO/IL, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.